Neuropathologic contributions to understanding AIDS and the central nervous system

Brain Pathology

Volumn 17, Issue 2, 2007, Pages 197-208

  Scaravilli, Francesco ^a   Bazille, Céline ^b   Gray, Françoise ^b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOPSY; BRAIN DEGENERATION; CAUSE OF DEATH; CELL DAMAGE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL STUDY; COGNITIVE DEFECT; DEMENTIA; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DISEASE COURSE; EPIDEMIC; EXPERIMENTAL STUDY; FATALITY; GENETIC ANALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NERVE CELL; NEUROLOGICAL COMPLICATION; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PATHOLOGY; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; TREATMENT OUTCOME; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CENTRAL NERVOUS SYSTEM; HISTORY, 20TH CENTURY; HIV; HUMANS; NEUROLOGY; PATHOLOGY, CLINICAL;

EID: 33947524793     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2007.00047.x     Document Type: Review

References (161)

1. Acheampong EA, Parveen Z, Muthoga LW, Lakayeh M, Mukhtar M, Pomerantz RJ (2005) Human immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases. J Virol 79:4257-4269.
2. Adamson DC, Wildemann B, Sasaki M (1996) Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274:1917-21.
3. Adle Biassette H, Chrétien F, Wingertsmann L, Henry C, Ereau T, Scaravilli F, Tardieu M, Gray F (1999) Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 25:123-133.
4. Adle-Biassette H, Levy Y, Colombel M, Poron F, Natchev S, Keohane C, Gray F (1995) Neuronal apoptosis in HIV infection in adults. Neuopathol Appl Neurobiol 21:218-227.
5. An SF, Ciardi A, Giometto B, Scaravilli T, Gray F, Scaravilli F (1996) Investigation on the expression of major histocompatibility complex class II and cytokines and detection of HIV-1 DNA within brains of asymptomatic and symptomatic HIV-1-positive patients. Acta Neuropathol 91:494-503.
6. An SF, Giometto B, Scaravilli F (1996) HIV-1 DNA in brains in AIDS and pre-AIDS: correlation with the stage of the disease. Ann Neurol 40:611-617.
7. An SF, Giometto B, Scaravilli T, Tavolato B, Gray F, Scaravilli F (1996) Programmed cell death in brains of HIV-1-positive AIDS and pre-AIDS patients. Acta Neuropathol 91:169-173.
8. An SF, Giometto B, Groves M, Miller R, Beckett AAJ, Gray F, Tavolato B, Scaravilli F (1997) Axonal damage revealed by accumulation of β-APP in HIV-positive individuals without AIDS. J Neuropathol Exp Neurol 56:1262-1268.
9. An SF, Groves M, Giometto B, Becket AAJ, Scaravilli F (1999) Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/in situ hybridisation technique. Acta Neuropathol 98:481-487.
10. Anonymous (1982) Opportunistic infections and Kaposi's sarcoma among Haitians in the United States. Conn Med 46:727-728.
11. Artigas J, Grosse G, Niedobitek F (1990) Vacuolar myelopathy in AIDS. A morphological analysis. Pathol Res Pract 186:228-237.
12. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J (1997) Positive effects of combined antiretroviral therapy on CD4+ T cells homeostasis and function in advanced HIV cases. Science 277:112-116.
13. Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R, Pomerantz RJ (1996) Cell reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10:573-585.
14. Banks WA, Freed EO, Wolf KM, Robinson SM, Franko M, Kumar VB (2001) Transport of human immunodeficiency virus type 1 pseudoviruses across the blood-brain barrier: role of envelope proteins and adsorptive endocytosis. J Virol 75:4681-4691.
15. Barré-Sinoussi F, Cherman JC, Rey F, Nugeyre M, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L (1983) Isolation of T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome. Science 220:868-871.
16. Boven LA, Gomes L, Henry C, Gray F, Verhoef J, Portegies P, Tardieu M, Nottet HS (1999) Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. J Immunol 162:4319-4327.
17. Bell JE, Brettle RP, Chiswick A, Simmonds P (1998) HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 121:2043-2052.
18. Bissel SJ, Wiley CA (2004) Human immunodeficiency virus infection of the brain: pitfalls in evaluating infected/affected cell populations. Brain Pathol 14:97-108.
19. Boven LA, Middle J, Verhoef J, De Groot CJ, Nottet HS (2000) Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV-a-associated dementia. Neuropathol Appl Neurobiol 26:356-360.
20. Breton G, Seilhean D, Chérin P, Herson S, Benveniste O (2002) Paradoxical intracranial cryptococcoma in a Human Immunodeficiency Virusinfected man being treated with combination Antiretroviral Therapy. Am J Med 113:155-157.
21. Brew BJ, Rosenblum M, Cronin K, Price RW (1995) AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol 38:563-570.
22. Bruce-Keller AJ, Chauhan A, Dimayuga FO, Gee J, Keller JN, Nath A (2003) Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicityand gliosis in rat brain. J Neurosci 23:8417-8422.
23. Budka H (1986) Multinucleated giant cells in brain: a hallmark of the acquired immune deficiency syndrome (AIDS). Acta Neuropathol 69:253-258.
24. Budka H, Costanzi G, Cristina S, Lechi A, Parravicini C, Trabattoni R, Vago L (1987) Brain pathology induced by the infection with the human immunodeficiency virus (AIDS). Acta Neuropathol 75:186-198.
25. Budka H, Maier H, Pokl P (1988) Human immunodeficiency virus in vacuolar myelopathy of the acquired immunodeficiency syndrome. N Engl J Med 319:1667-1668.
26. Budka H, Wiley CA, Kleihues P, Artigas J, Asbury AK, Cho ES, Cornblath DR, Dal Canto MC, De Girolami U, Dickson D, Epstein LG, Esiri MM, Giangaspero F, Gosztonyi G, Gray F, Griffin JW, Hénin D, Iwasaki Y, Janssen RS, Johnson RT, Lantos PL, Lyman WD, McArthur JC, Nagashima K, Peress N, Petito CK, Price RW, Rhodes RH, Rosenblum M, Said G, Scaravilli F, Sharer LR, Vinters HV (1991) HIV associated disease of the nervous system: review and nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1:143-152.
27. Carne CA, Tedder RS, Smith A, Sutherland S, Elkington SG, Daly HM, Preston FE, Craskey J (1985) Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet ii:1206-1208.
28. Chrétien F, Gray F, Lescs MC, Geny C, Dubreuil-Lemaire ML, Ricolfi F, Baudrimont M, Levy Y, Sobel A, Vinters HV (1993) Acute varicella-zoster virus ventriculitis and meningo-myelo-radiculitis in acquired immunodeficiency syndrome. Acta Neuropathol 86:659-665.
29. Ciardi A, Sinclair E, Scaravilli F, Harcourt-Webster NJ, Lucas S (1990) Involvement of the cerebral cortex in HIV-encephalopathy. A morphological and immuno-histochemical study. Acta Neuropathol 81:51-59.
30. Collazos J, Mayo J, Martinez E, Blanco MS (1999) Contrast-enhancing progressive multifocal leukoencephalopathy as an immune reconstitution event in AIDS patients. AIDS 13:426-428.
31. Crump JA, Tyrer MJ, Lloyd-Owen SJ, Han LY, Lipman MC, Johnson MA (1998) Miliary tuberculosis with paradoxical expansion of intracranial tuberculomas complicating immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy. Clin Infect Dis 26:1008-1009.
32. Dalgliesh AG, Beverley PCL, Clapman PR, Crawford DH, Greaves MF, Weiss RA (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:767-768.
33. Daniel MD, Letvin NL, King NW, Kannagi M, Sehgal PK, Hunt RD, Kanki PJ, Essex M, Desrosiers RC (1985) Isolation of t-cell tropic HTLV-III-like retrovirus from macaques. Science 228:1201-1204.
34. Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, Young SA, Mills RG, Wachsman W, Wiley CA (1992) Early viral brain invasion in iatrogenic human immunodefiency virus infection. Neurology 42:1736-1739.
35. De la Grandmaison GL, Carlier R, Chrétien F, De Truchis P, Orlikowski D, Gray F (2005) "Burnt out" varicella-zoster-virus encephalitis in an AIDS patient following treatment by highly active antiretroviral therapy. Clin Radiol 60:613-617.
36. Denning DW, Anderson J, Rudge P, Smith H (1987) Acute myelopathy associated with primary infection with human immunodeficiency virus. BMJ 294:143-144.
37. Dewhurst S, Gelbard HA, Fine SM (1996) Neuropathogenesis of AIDS. Mol Med Today 2:16-23.
38. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
39. Epstein LG, Sharer LR, Goudsmit J (1988) Neurological and neuropathological features of human immunodeficiency virus infection in children. Ann Neurol 23:s19-23.
40. Esiri MM, Scaravilli F, Millard PR, Harcourt-Webster JN (1989) Neuropathology of HIV infection in haemophiliacs: comparative necropsy study. BMJ 299:1312-1315.
41. Evans LA, Levy JA (1989) Characteristics of HIV infection and pathogenesis. Biochem Biophys Acta 989:237-254.
42. Everall I, Barnes H, Spargo E, Lantos P (1995) Assessment of neuronal density in the putamen in human immunodeficiency virus (HIV) infection. Application of stereology and spatial analysis of quadrats. J Neurovirol 1:126-129.
43. Everall IP, Glass JD, McArthur J, Spargo E, Lantos P (1994) Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia. Acta Neuropathol 88:538-544.
44. Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I, Mallory M, Masliah E (1999) Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol 9:209-217.
45. Everall IP, Luthert P, Lantos PL (1993) A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia. J Neuropathol Exp Neurol 52:561-556.
46. Fauci AS, Macher AM, Longo DL, Lane HC, Rook AH, Masur H, Gelmann EP (1984) Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic and therapeutic considerations. Ann Int Med 100:92-106.
47. Feng Y, Broder CC, Kennedy PE, Berger EA (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven transmembrane, G protein-coupled receptor. Science 272:872-877.
48. Ferrarese C, Aliprandi A, Tremolizzo L, Stanzani L, De Micheli A, Dolara A, Frattola L (2001) Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 57:671-675.
49. Foudraine NA, Hovenkamp E, Notermans DW, Meenhorst PL, Klein MR, Lange JM, Miedema F, Reiss P (1999) Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients. AIDS 13:177-184.
50. Gallo RC, Salahuddin SZ, Popovic M, Shaerer GM, Kaplan M, Haynes BF, Palker TJ, Redfield R, Oleske J, Safai B, White G, Foster P, Markham PD (1984) Frequent detection and isolation of cytopathic retrovirus (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:500-503.
51. Gao F, Bailes E, Robertson DL, Chen Y, Rodenbug CM, Michael SF, Cummins LB, Arthur LO, Peters M, Shaw GM, Sharp PM, Hahn BH (1999) Origin of HIV-1in the chimpanzee Pan troglodytes troglodytes. Nature 397:436-441.
52. Geddes JF, Battacharjee MB, Savage K, Scaravilli F, McLaughlin JE (1992) Primary cerebral lymphoma: a study of 47 cases probed for Epstein-Barr virus genome. J Clin Pathol 45:587-90.
53. Geiger KD, Stoldt P, Schlote W, Derouiche A (2006) Ezrin immunoreactivity reveals specific astrocyte activation in cerebral HIV. J Neuropathol Exp Neurol 65:87-96.
54. Gelbard HA, James HJ, Sharer LR, Perry SW, Saito Y, Kazee AM, Blumberg BM, Epstein LG (1995) Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol Appl Neurobiol 21:208-217.
55. Giometto B, An SF, Groves M, Scaravilli T, Geddes JF, Miller R, Tavolato B, Beckett AA, Scaravilli F (1997) Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neurophysiological abnormalities. Ann Neurol 42:34-40.
56. Glass JD, Wesselingh SL, Selnes OA, McArthur JC (1993) Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 43:2230-2237.
57. Goldstick L, Mandybur TI, Bode R (1985) Spinal cord degeneration in AIDS. Neurology 35:103-106.
58. Gras G, Chrétien F, Vallat-Decouvelaere AV, Le Pavec G, Porcheray F, Bousset C, Leone C, Mialocq P, Dereuddre-Bosquet N, Clayette P, Le Grand R, Luminon C, Dormont D, Gray F (2003) Regulated expression of sodium-dependent glutamate transporters and synthetase: a neuroprotective role for activated microglia and macrophages in HIV infection? Brain Pathol 13:211-222.
59. Gray F, Adle-Biassette H, Chrétien F, Lorin de la Grandmaison GL, Force G, Keohane C (2001) Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol 20:146-155.
60. Gray F, Bazille C, Adle-Biassette H, Mikol J, Moulignier A, Scaravilli F (2005) Central nervous system immune reconstitution disease in AIDS patients receiving highly active antiretroviral treatment. J Neurovirol 11(Suppl. 3):16-22.
61. Gray F, Chrétien F, Vallat-Decouvelaere AV, Scaravilli F (2003) The changing pattern of HIV neuropathology in the HAART era. J Neuropathol Exp Neurol 62:429-440.
62. Gray F, Geny C, Lionnet F, Dournon E, Fenelon G, Gherardi R, Poirier J (1991) Neuropathologic study of 135 adult cases of acquired immunodeficiency syndrome (AIDS). Ann Pathol 11:236-247 (in French).
63. Gray F, Gherardi R, Keohane C, Favolini M, Sobel A, Poirier J (1988) Pathology of the central nervous system in 40 cases of acquired immune deficiency syndrome (AIDS). Neuropathol Appl Neurobiol 14:365-380.
64. Gray F, Haug H, Chimelli L, Geny C, Gaston A, Scaravilli F, Budka H (1991) Prominent cortical atrophy with neuronal loss as correlate of human immunodeficiency virus encephalopathy. Acta Neuropathol 82:229-233.
65. Gray F, Lescs MC, Keohane C, Paraire F, Marc B, Durigon M, Gherardi R (1992) Early brain changes in HIV infection: neuropathological study of 11 HIV-seropositive, no-AIDS cases. J Neuropathol Exp Neurol 51:177-185.
66. Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS (1981) Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 41:4253-4261.
67. Harcourt-Webster JN (1993) General pathology. In: The Neuropathology of HIV Infection. F Scaravilli (ed.), pp. 53-98. Springer: London.
68. Haughey NJ, Nath A, Mattson NR, Slevin JT, Geiger JD (2001) HIV-1 Tat through phosphorylation of NMDA receptors petentiates glutamate excitotoxicity. J Neurochem 78:457-467.
69. Hénin D, Duyckaerts C, Chaunu MP, Vazeux R, Brousse N, Rozenbaum W, Hauw JJ (1987) Etude neuropathologique de 31 cas de syndrome d'immunodépression acquise. Rev Neurol (Paris) 143:631-642.
70. Heyes MP, Ellis RJ, Ryan L, Childers ME, Grant I, Wolfson T, Archibald S, Jernigan TL, HNRC Group, HIV Neurobehavioural Research Center (2001) Elevated cerebro spinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection. Brain 124:1033-1042.
71. Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, Resnick L, Felsenstein D, Andrews CA, Hirsch MS (1985) Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurological syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 313:1493-1497.
72. Hoffmann C, Tabrizian S, Wolf E, Eggers C, Stoehr A, Plettenberg A, Buhk T, Stellbrink HJ, Horst HA, Jager H, Rosenkranz T (2001) Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 15:2119-2127.
73. Hoffmann S, Horst HA, Albrecht H, Schlote W (2003) Progressive multifocal leukoencephalopathy with unusual inflammatory response during antiretroviral treatment. J Neurol Neurosurg Psychiat 74:1142-1144.
74. Hooper DC, Pruitt AA, Rubin RH (1982) Central nervous system infection in the chronically immunosuppressed. Medicine 61:166-188.
75. Jacobson MA, Zegans M, Pavan PR, O'Donnell JJ, Sattler F, Rao N, Owens S, Pollard R (1997) Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 349:1143-1145.
76. Jellinger KA, Setinek U, Drilicek M, Bohm G, Steurer A, Lintner F (2000) Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta Neuropathol 100:213-220.
77. Jerene D, Naess A, Lindtjorn B (2006) Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients. AIDS Res Ther 3:10.
78. Johnson RT, Glass JD, McArthur JC, Chesebro BW (1996) Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome. Ann Neurol 39:392-395.
79. Kamin SS, Petito CK (1991) Idiopathic myelopathies with white matter vacuolation in nonacquired immunodeficiency patients. Hum Pathol 22:816-824.
80. Kaul M, Garden GA, Lipton SA (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988-994.
81. Kimura-Kuroda J, Nagashima K, Yasui K (1994) Inhibition of myelin formation by HIV-1 gp-120 in rat cerebral cortex culture. Arch Virol 137:81-99.
82. King MD, Perlino CA, Cinnamon J, Jernigan JA (2002) Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy. AIDS 13:724-726.
83. Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman JC, Montagnier L (1984) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312:767-768.
84. Kotecha N, George MJ, Smith TW, Corvi F, Litofsky NS (1998) Enhancing progressive multifocal leukoencephalopathy: an indicator of improved immune status? Am J Med 105:541-543.
85. Kovacs JA, Kovacs AA, Polis M, Wright WC, Gill VJ, Tuazon CV, Gelmann EP, Lane HC, Longfield R, Overturf G, Macher AM, Fauci AS, Parrillo JE, Bennett JE, Masur H (1985) Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 103:533-538.
86. Lang W, Miklossy J, Deruaz JP, Pizzolato GP, Schaffner T, Gessaga E, Kleihues P (1989) Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol 77:379-390.
87. Langford TD, Letendre SL, Marcotte TD, Ellis RJ, McCutchan JA, Grant I, Mallory ME, Hansen LA, Archibald S, Jernigan T, Masliah E (2002) Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 16:1019-1029.
88. Lazarini F, Seilhean D, Rosenblum O, Suarez S, Conquy L, Uchihara T, Sazdovitch V, Mokhtari K, Maisonobe T, Boussin F, Katlama C, Bricaire F, Duyckaerts C, Hauw JJ (1997) Human immunodeficiency virus type 1 DNA and RNA load in brains of demented and nondemented patients with acquired immunodeficiency syndrome. J Neurovirol 3:299-303.
89. Lawn SD, Badri M, Wood R (2005) Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in South African cohort. AIDS 19:2109-2116.
90. Levy RM, Bredesen DE, Rosenblum ML (1988) Opportunistic central nervous system pathology in patients with AIDS. Ann Neurol 23(Suppl.):S7-S12.
91. Li W, Galey D, Mattson MP, Nath A (2005) Molecular and cellular mechanisms of neuronal cell death in HIV dementia. Neurotox Res 8:119-134.
92. Lipton SA (1991) HIV-related neurotoxicity. Brain Pathol 1:193-199.
93. Luft BJ, Brooks RG, Conley FK, McCabe RE, Remington JS (1984) Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. JAMA 252:913-917.
94. Maier H, Budka H, Lassmann H, Pohl P (1989) Vacuolar myelopathy with multinucleated giant cells in the acquired immunodeficiency syndrome (AIDS). Light and electron microscopic distribution of the human immunodeficiency virus (HIV) antigens. Acta Neuropathol 78:497-503.
95. Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A (2000) Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiat 69:376-380.
96. Masliah E, Eaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I (1997) Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 42:963-972.
97. Meltzer MS, Gendelman HE (1992) Mononuclear phagocytes as targets, tissue reservoirs, and immunoregulatory cells in human immunodeficiency virus disease. Curr Top Microbiol Immunol 181:239-263.
98. Miller RF, Isaacson PG, Hall-Craggs M, Lucas S, Gray F, Scaravilli F, An SF (2004) Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART. Acta Neuropathol 108:17-23.
99. Miralles P, Berenguer J, Lacruz C, Cosin J, Lopez JC, Padilla B, Munoz L, Garcia-de-Viedma D (2001) Inflammatory reactions in progressive multifocal leukoencephalopathy after highly acive antiretroviral therapy. AIDS 15:190-192.
100. Mizusawa H, Hirano A, Llena JF, Shintaku M (1988) Cerebrovascular lesions in acquired immunodeficiency syndrome (AIDS). Acta Neuropathol 76:451-457.
101. Morgello S, Cho E-S, Nielsen S, Devinsky O, Petito CK (1987) Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: an autopsy study of 30 cases and a review of the literature. Hum Pathol 18:289-297.
102. Moore JP, Stevenson M (2000) New targets for inhibitors of HIV-1 replication. Nat Rev Mol Cell Biol 1:40-49.
103. Navia BA, Cho E-S, Petito CK, Price RW (1986) The AIDS dementia complex: II. Neuropathology. Ann Neurol 19:525-535.
104. Nahmias AJ, Weiss J, Yao X, Lee F, Kodsi R, Schanfield M, Matthews T, Bolognesi D, Durack D, Motulsky A, Kanki P, Essex M (1986) Evidence for human infection with an HTLVIII/LAV-like virus in Central Africa, 1959. Lancet i:1279-1280.
105. Nath A, Geiger J (1998) Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Progr Neurobiol 54:19-33.
106. Nath A, Conant K, Chen P, Scott C, Major EO (1999) Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J Biol Chem 274:17098-17101.
107. Nathan DG (1998) Clinical research: perceptions, reality, and proposed solutions. National Institute of Health Director's Panel on Clinical Research. JAMA 280:1427-1431.
108. Nuovo GJ, Gallery F, MacConnell P, Braun A (1994) in situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. Am J Pathol 144:659-666.
109. Pakker NG, Ross MTL, van Leeuwen R, de Long MD, Koot M, Reiss P, Lange JM, Miedema F, Danner SA, Shellekens PT (1997) Patterns of T cell repopulation, virus load reduction and restoration of T cell function in HIV-infected persons during therapy with different antiretrovirals. J Acquir Immne Defic Syndr Hum Retrovirol 16:318-326.
110. Petito CK, Cask KS (1992) Blood brain barrier abnormality in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in post-mortem brain. Ann Neurol 32:658-666.
111. Petito CK, Cho E-S, Lemann W, Navia BA, Price RW (1986) Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol 45:635-646.
112. Petito CK, Navia BA, Cho E-S, Jordan BD, George DC, Price RW (1985) Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with acquired immunodeficiency syndrome. N Engl J Med 312:874-879.
113. Petito CK, Roberts B (1995) Evidence of apoptotic cell death in HIV encephalitis. Am. J Pathol 146:1121-1130.
114. Petito CK, Roberts B, Cantando JD, Rabinstein A, Duncan R (2001) Hippocampal injury and alterations in neuronal chemochine co-receptor expression in patients with AIDS. J Neuropathol Exp Neurol 60:377-385.
115. Phoolcharoen W (1998) HIV/AIDS prevention in Thailand: success and challenges. Science 280:1873-1874.
116. Popovic M, Sarngadharan MG, Read E, Gallo RC (1984) Detection, isolation and continuous production of cytopathic retrovirus (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497-500.
117. Power C, Kong PA, Crawford TO, Wesselingh S, Glass JD, McArthur JC, Trapp BD (1993) Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain-barrier. Ann Neurol 34:339-350.
118. Resnick L, Burger JR, Shapshak P, Tourtellotte WW (1988) Early penetration of the blood-brainbarrier by HIV. Neurology 38:9-14.
119. Sacktor NC, Lyles RH, Skolasky R, Anderson DE, McArthur JC, Mcarlane G, Selnes OA, Becker JT, Cohen B, Wesch J, Miller EN (1999) The multicenter AIDS Cohort Study. HIV-1-related neurological disease incidence changes in the era of highly active antiretroviral therapy. Neurology 52:A252-A253.
120. Saito Y, Sharer LR, Epstein LG, Michaels J, Mintz M, Louder M, Golding K, Cvetkovich TA, Blumberg BM (1994) Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in post-mortem pediatric central nervous tissue. Neurology 44:474-481.
121. Scaravilli F, Daniel SE, Harcourt-Webster N, Guiloff RJ (1989) Chronic basal meningitis and vasculitis in acquired immunodeficiency syndrome. A possible role for human immunodeficiency virus. Arch Pathol Lab Med 113:192-195.
122. Schmidbauer M, Huemer M, Cristina S, Trabattoni GR, Budka H (1982) Morphological spectrum, distribution and clinical correlations of white matter lesions in AIDS brains. Neuropathol Appl Neurobiol 18:489-501.
123. Schmidt-Westhausen AM, Priepke F, Bergmann FJ, Reichart PA (2000) Decline in the rate of opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med 29:336-341.
124. Seilhean D, Duyckaerts C, Vazeux R, Bolgert F, Brunet P, Katlama C, Gentilini M, Hauw JJ (1993) HIV-associated cognitive/motor complex: absence of neuronal loss in the cerebral neocortex. Neurology 43:1492-1499.
125. Seilhean D, Dzia-Lepfoundzou A, Sazdovitch V, Cannella B, Raine CS, Katlama C, Bricaire F, Duyckaerts C, Hauw JJ (1997) Astrocytic adhesion molecules are increased in HIV-associated cognitive/motor complex. Neuropathol Appl Neurobiol 23:83-92.
126. Shacker T, Collier AC, Hughes J, Shea T, Corey L (1996) Clinical and epidemiologic features of primary HIV infection. Ann Int Med 125:257-264.
127. Sharer LR (1992) Pathology of HIV-1 infection of the central nervous system. A review. J Neuropathol Exp Neurol 51:3-11.
128. Sharer LR, Cho ES (1989) Neuropathology of HIV infection: adults vs. children. Progr AIDS Pathol 1:131-141.
129. Sharer LR, Cho E-S, Epstein LG (1985) Multinucleated giant cells and HTLV-III in AIDS encephalopathy. Hum Pathol 16:760.
130. Sharer LR, Dowling PC, Michaels J, Cook SD, Menonna J, Blumberg BM, Epstein LG (1990) Spinal cord disease in children with HIV-1 infection: a combined molecular biological and neuropathological study. Neuropathol Appl Neurobiol 16:317-331.
131. Sharer LR, Epstein LG, Cho E-S, Joshi VV, Meyenhofer MF, Rankin LF, Petito CK (1986) Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain. Hum Pathol 17:271-284.
132. Sharer LR, Saito Y, Epstein LG, Blumberg BM (1994) Detection of HIV-1 DNA in pediatric AIDS brain tissue by two step ISPCR. Adv Neuroimmunol 4:283-285.
133. Shaw GM, Harper ME, Hahn BH, Epstein LG, Gajdusek DC, Prive RW, Navia BA, Petito CK, O'Hara CJ, Groopman JE, Cho E-S, Oleske JM, Wong-Staal F, Gallo RC (1985) HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 227:177-182.
134. Shelburne SA, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DW, Gathe JC Jr, Visnegarwala F, Trautner BW (2002) Immune reconstruction inflammatory syndrome. Emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 81:213-227.
135. Shi B, De Girolami U, He J, Wang S, Lorenzo A, Busciglio J, Gabuzda D (1996) Apoptosis induced by HIV-1 infection of the central nervous system. J Clin Invest 98:1979-1990.
136. Shi B, Raina J, Lorenzo A, Busciglio J, Gabuzda D (1998) Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implication for HIV-1 dementia. J Neurovirol 4:281-290.
137. Sinclair E, Gray F, Ciardi A, Scaravilli F (1994) Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients. J Neuropathol Exp Neurol 53:43-50.
138. Smith TW, De Girolami U, Hénin D, Bolgert F, Hauw JJ (1990) Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J Neuropathol Exp Neurol 49:357-370.
139. Smyth MJ, Kelly JM, Sutton VR, Davis JE, Browne KA, Sayers TJ, Trapani JA (2001) Unlocking the secrets of cytoplasmic granule proteins. J Leukoc Biol 70:18-29.
140. Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka CE, Posner JB (1983) Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14:403-418.
141. Strittmatter C, Lang W, Wiestler OD, Kleihues P (1992) The changing pattern of human immunodeficiency virus- associated cerebral toxoplasmosis: a study of 46 postmortem cases. Acta Neuropathologica 83:475-481.
142. Surtees R, Hyland K, Smith I (1990) Central nervous system methyl-group metabolism in children with neurological complications of HIV infections. Lancet 335:619-621.
143. Tan SV, Guiloff RJ, Scaravilli F (1995) AIDS-associated vacuolar myelopathy. A morphometric study. Brain 118:1247-1261.
144. Tantisiriwat W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ (1998) Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clin Infect Dis 28:1152-1154.
145. Tornatore C, Chandra R, Berger JR, Major EO (1994) HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44:481-487.
146. Torre D, Speranza F, Martregani R (2005) Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection. HIV Med 6:66-78.
147. Tyor WR, Glass JD, Baumrind N, McArthur JC, Griffin JW, Becker PS, Griffin DE (1993) Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology 43:1002-1009.
148. Vallat-Decouvelaere AV, Chrétien F, Gras G, Le Pavec G, Dormont D, Gray F (2003) Expression of excitatory amino acid-transporter-1 in brain macrophages and microglia of HIV patients. A neuroprotective role for microglia? J Neuropathol Exp Neurol 62:475-485.
149. Vallat AV, De Girolami U, He J, Mhashilkar A, Marasco W, Shi B, Gray F, Bell J, Keohane C, Smith TW, Gabuzda D (1998) Localization of HIV-1 coreceptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol 152:167-178.
150. Vazeux R, Brousse N, Jarry A, Hénin D, Marche C, Vedrenne C, Mikol J, Wolff M, Michou C, Rozenbaum W, Bureau J-F, Montagnier L, Brahic M (1987) AIDS subacute encephalitis. Identification of HIV-infected cells. Am J Pathol 126:403-410.
151. Vendrely A, Bienvenu B, Gasnault J, Thiebault JB, Salmon D, Gray F (2005) Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol 109:449-455.
152. Vinters H, Guerra WF, Eppolito L, Keith PE (1988) Necrotizing vasculitis of the nervous system in a patient with AIDS-related complex. Neuropathol Appl Neurobiol 14:417-424.
153. Vinters H, Tomiyasu U, Anders KH (1989) Neuropathologic complications of infection with the human immunodeficiency virus (HIV). Adv AIDS Pathol 1:101-130.
154. Weber JN (1993) HIV infection: a cellular approach. In: The Neuropathology of HIV Infection. F Scaravilli (ed.), pp. 1-8. Springer: London.
155. Weis S, Haug H, Budka H (1993) Astroglial changes in the cerebral cortex of AIDS brains: a morphometric and immunohistochemical investigation. Neuropathol Appl Neurobiol 19:329-335.
156. Weiss R (1985) Human T-cell retroviruses. In: RNA Tumor Viruses, 2nd edn, vol 2, Supplements and appendices. R Weiss, N Teich, H Varmus, J Coffin (eds), pp. 405-485. Cold Spring Harbor Laboratory: New York.
157. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MG (1986) Cellular localisation of human immunodeficiency virus infection within the brains of acquired immunodeficiency syndrome patients. Proc Natl Acad Sci USA 83:7089-7093.
158. Wiley CA, Achim C (1994) Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 36:673-676.
159. Wood ML, MacGinley R, Eisen DP, Allworth AM (1998) HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. AIDS 12:1491-1494.
160. Xu Y, Kulkosky J, Acheampong E, Nunnari G, Sullivan J, Pomerantz RJ (2004) HIV-1-mediated apoptosis of neuronal cells: proximal molecular mechanisms of HIV-1-induced encephalopathy. Proc Natl Acad Sci USA 101:7070-7075.
161. Yankner BA, Skolnik PR, Shoukimas GM, Gabuzda DH, Sobel RA, Ho DD (1986) Cerebral granulomatous angiitis associated with isolation of human lymphotropic virus type III from the central nervous system. Ann Neurol 20:362-364.